Advertisement
Screener

Vaxart, Inc. (VXRT) Diluted Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Vaxart, Inc. Diluted Shares Outstanding (Weighted Average)

Vaxart, Inc. (VXRT) reported Diluted Shares Outstanding (Weighted Average) of 242.18 million shares for the 3-month period ending 2026-03-31, per its S-1 filed 2026-05-08.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-05-08

  • Vaxart, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 242.18M shares, a 6.26% increase year-over-year.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 227.92M shares.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2019-03-31 was 7.30M shares, a 37.76% increase year-over-year.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2018-03-31 was 5.30M shares, a 3806.70% increase year-over-year.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for fiscal 2017 was 38.64M shares, a 0.02% increase from fiscal 2016.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for fiscal 2016 was 38.64M shares, a 9.26% increase from fiscal 2015.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for fiscal 2015 was 35.36M shares, a 12.80% increase from fiscal 2014.
  • Vaxart, Inc. weighted average number of shares outstanding, diluted for fiscal 2014 was 31.35M shares, a 11.09% increase from fiscal 2013.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 12 monthWeighted Average Number of Shares Outstanding, Diluted 12 month as first filed
2026-03-31242.18M shares
S-1 · filed 2026-05-08
2025-12-31230.35M shares
S-1 · filed 2026-05-08
2025-03-31227.92M shares
S-1 · filed 2026-05-08
2024-12-31202.14M shares
S-1 · filed 2026-05-08
2019-03-317.30M shares
10-Q · filed 2019-05-09
2018-03-315.30M shares
10-Q · filed 2019-05-09
21.97M shares
derived: average of 2 quarters · filed 2019-05-09
27.53M shares
derived: average of 3 quarters · filed 2019-05-09
30.31M shares
derived: average of 4 quarters · filed 2019-05-09
2017-12-3138.65M shares
10-Q · filed 2018-02-06
38.65M shares
10-Q · filed 2018-02-06
38.65M shares
derived: average of 3 quarters · filed 2018-02-06
29.02M shares
derived: average of 4 quarters · filed 2018-05-15
2017-09-3038.65M shares
10-Q · filed 2017-11-07
38.65M shares
derived: average of 2 quarters · filed 2017-11-07
25.81M shares
derived: average of 3 quarters · filed 2018-05-15
29.02M shares
derived: average of 4 quarters · filed 2018-05-15
2017-06-3038.65M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01
19.39M shares
derived: average of 2 quarters · filed 2018-05-15
25.81M shares
derived: average of 3 quarters · filed 2018-05-15
38.64M shares
10-K · filed 2017-09-01
2017-03-31135.66K shares
10-Q · filed 2018-05-15
38.65M shares
10-Q · filed 2017-05-08
19.39M shares
derived: average of 2 quarters · filed 2018-05-15
38.64M shares
10-Q · filed 2017-05-08
29.01M shares
derived: average of 4 quarters · filed 2018-05-15
2016-12-3138.64M shares
10-Q · filed 2018-02-06
38.64M shares
10-Q · filed 2018-02-06
38.64M shares
derived: average of 3 quarters · filed 2018-02-06
38.64M shares
derived: average of 4 quarters · filed 2018-02-06
2016-09-3038.64M shares
10-Q · filed 2017-11-07
38.64M shares
derived: average of 2 quarters · filed 2017-11-07
38.64M shares
derived: average of 3 quarters · filed 2017-11-07
38.64M shares
derived: average of 4 quarters · filed 2017-11-07
2016-06-3038.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01
38.64M shares
derived: average of 2 quarters · filed 2017-09-01
38.64M shares
derived: average of 3 quarters · filed 2017-09-01
38.64M shares
10-K · filed 2017-09-01
2016-03-3138.64M shares
10-Q · filed 2017-05-08
38.64M shares
derived: average of 2 quarters · filed 2017-05-08
38.63M shares
10-Q · filed 2017-05-08
37.99M shares
derived: average of 4 quarters · filed 2017-05-08
2015-12-3138.64M shares
10-Q · filed 2017-02-06
38.63M shares
10-Q · filed 2017-02-06
37.77M shares
derived: average of 3 quarters · filed 2017-02-06
37.12M shares
derived: average of 4 quarters · filed 2017-02-06
2015-09-3038.62M shares
10-Q · filed 2016-11-08
37.34M shares
derived: average of 2 quarters · filed 2016-11-08
36.61M shares
derived: average of 3 quarters · filed 2016-11-08
36.23M shares
derived: average of 4 quarters · filed 2016-11-08
2015-06-3036.06M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
35.60M shares
derived: average of 2 quarters · filed 2016-09-13
35.44M shares
derived: average of 3 quarters · filed 2016-09-13
35.36M shares
10-K · filed 2016-09-13
35.37M shares
10-K · filed 2015-09-11
2015-03-3135.14M shares
10-Q · filed 2016-05-10
35.12M shares
derived: average of 2 quarters · filed 2016-05-10
35.13M shares
10-Q · filed 2016-05-10
35.07M shares
derived: average of 4 quarters · filed 2016-09-13
2014-12-3135.10M shares
10-Q · filed 2016-02-08
35.10M shares
10-Q · filed 2016-02-08
35.05M shares
derived: average of 3 quarters · filed 2016-09-13
34.85M shares
derived: average of 4 quarters · filed 2016-09-13
2014-09-3035.03M shares
10-Q · filed 2015-11-06
35.02M shares
derived: average of 2 quarters · filed 2016-09-13
34.77M shares
derived: average of 3 quarters · filed 2016-09-13
33.15M shares
derived: average of 4 quarters · filed 2016-09-13
2014-06-3035.01M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
34.64M shares
derived: average of 2 quarters · filed 2016-09-13
32.52M shares
derived: average of 3 quarters · filed 2016-09-13
31.35M shares
10-K · filed 2016-09-13
2014-03-3134.26M shares
10-Q · filed 2015-05-08
31.28M shares
derived: average of 2 quarters · filed 2015-05-08
30.13M shares
10-Q · filed 2015-05-08
29.82M shares
derived: average of 4 quarters · filed 2015-09-11
2013-12-3128.29M shares
10-Q · filed 2015-02-06
28.29M shares
10-Q · filed 2015-02-06
28.34M shares
derived: average of 3 quarters · filed 2015-09-11
28.30M shares
derived: average of 4 quarters · filed 2015-09-11
2013-09-3028.29M shares
10-Q · filed 2014-11-07
28.36M shares
derived: average of 2 quarters · filed 2015-09-11
28.30M shares
derived: average of 3 quarters · filed 2015-09-11
28.32M shares
derived: average of 4 quarters · filed 2015-09-11
2013-06-3028.43M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11
28.31M shares
derived: average of 2 quarters · filed 2015-09-11
28.32M shares
derived: average of 3 quarters · filed 2015-09-11
28.22M shares
10-K · filed 2015-09-11
2013-03-3128.18M shares
10-Q · filed 2014-05-12
28.27M shares
derived: average of 2 quarters · filed 2014-05-12
28.15M shares
10-Q · filed 2014-05-12
19.85M shares
derived: average of 4 quarters · filed 2014-05-12
2012-12-3128.35M shares
10-Q · filed 2014-02-10
28.14M shares
10-Q · filed 2014-02-10
17.07M shares
derived: average of 3 quarters · filed 2014-02-10
18.48M shares
derived: average of 4 quarters · filed 2014-02-10
2012-09-3022.81M shares
10-Q · filed 2013-11-12
32.83M shares
10-Q · filed 2012-11-08
11.42M shares
derived: average of 2 quarters · filed 2013-11-12
39.30M shares
10-Q · filed 2012-11-08
17.06M shares
derived: average of 4 quarters · filed 2013-11-12
2012-06-3042.66K shares
10-Q · filed 2012-08-09
42.58K shares
10-Q · filed 2012-08-09
15.15M shares
derived: average of 3 quarters · filed 2013-05-10
22.71M shares
10-K · filed 2014-09-30
2012-03-3122.71M shares
10-Q · filed 2013-05-10
42.49M shares
10-Q · filed 2012-05-10
22.70M shares
derived: average of 2 quarters · filed 2013-05-10
22.71M shares
10-Q · filed 2013-05-10
21.96M shares
derived: average of 4 quarters · filed 2013-05-10
2011-12-3122.70M shares
10-Q · filed 2013-02-11
22.70M shares
10-Q · filed 2013-02-11
21.71M shares
derived: average of 3 quarters · filed 2013-02-11
42.34M shares
10-K · filed 2012-03-14
2011-09-2442.40M shares
10-Q · filed 2012-11-08
21.22M shares
derived: average of 2 quarters · filed 2012-08-09
42.27M shares
10-Q · filed 2012-11-08
31.63M shares
derived: average of 4 quarters · filed 2012-08-09
2011-06-3022.57M shares
10-K · filed 2013-09-27
2011-06-2542.31K shares
10-Q · filed 2012-08-09
42.31M shares
10-Q · filed 2011-08-03
42.22K shares
10-Q · filed 2012-08-09
42.22M shares
10-Q · filed 2011-08-03
28.05M shares
derived: average of 3 quarters · filed 2012-08-09
31.67M shares
derived: average of 4 quarters · filed 2012-08-09
2011-03-2642.25M shares
10-Q · filed 2012-05-10
42.05M shares
derived: average of 2 quarters · filed 2012-05-10
42.21M shares
derived: average of 3 quarters · filed 2012-05-10
42.75M shares
derived: average of 4 quarters · filed 2012-05-10
2010-12-2541.85M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14
42.19M shares
derived: average of 2 quarters · filed 2012-03-14
42.92M shares
derived: average of 3 quarters · filed 2012-03-14
44.44M shares
10-K · filed 2012-03-14
2010-09-2542.54M shares
10-Q · filed 2011-11-02
43.46M shares
derived: average of 2 quarters · filed 2011-11-02
45.30M shares
10-Q · filed 2011-11-02
2010-06-2644.38M shares
10-Q · filed 2011-08-03
46.69M shares
10-Q · filed 2011-08-03
2009-12-2650.63M shares
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B